chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fell unexpectedly; I injured my nose, tooth; I injured my nose, tooth; My arm pain is 7 out of 10; scared to get up.; This is a spontaneous report from a contactable consumer (patient). A 29-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection) via an unspecified route of administration on 28Apr2021 at 16:15 (at the age of 29-years-old) as a single dose in the left arm for COVID-19 immunisation and ibuprofen (ADVIL) from an unspecified date to an unspecified date at an unspecified dose (2) and frequency for an unspecified indication. Medical history included anxiety/depression (mitigated with SSRI) from an unspecified date and unspecified if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known drug allergies. Concomitant medications (taken within 2 weeks of vaccination) included escitalopram orally taken for an unspecified indication from an unspecified date to an unspecified date at 10mg, daily. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection) via an unspecified route of administration an unspecified date as a single dose for COVID-19 immunisation. On 29Apr2021 at 03:00 the patient experienced fell unexpectedly, I injured my nose, tooth, my arm pain is 7 out of 10 and scared to get up. The course of events was reported as follows: "Got up at 3am in the morning to take some Advil. Took 2 Advil then fell unexpectedly. Partner was awake and stated that I did not trip on anything. I did not have any previous dizziness or indications that I was going to faint (no night sweats, no stars or blurry vision, no muscle weakness). I injured my nose, tooth (no significant damage), and was scared to get up. My arm pain is 7 out of 10. I have no previous medical history of fainting after a vaccine." No treatment was received for the adverse events. The clinical outcomes of the events fell unexpectedly, I injured my nose, tooth, my arm pain is 7 out of 10 and scared to get up were recovered/resolved on an unspecified date in 2021. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
One week after vaccine I began to run a fever ranging between 99 and 101.; Have constant headache, for 5 days still has not gone away.; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Oct2021 at 17:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 04Nov2021 at 05:30, one week after the vaccine, the patient began to run fever ranging between 99 and 101(unspecified units). The patient also had a constant headache for 5 days that had not gone away at the time of this report. It had been 11 days since she received the vaccine. On 04Nov2021, the patient underwent body temperature test and the result was between 99 and 101(unspecified units). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since, the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events fever ranging between 99 and 101 was resolving, while the clinical outcome of the event constant headache was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Persistent vomiting, pallor, given IV fluid in ER with good results. Also received po ZOFRAN. Symptoms of vomiting started one hour after HIB injection.
At approximately 5 minutes after the injection, I experiences a short period of Rapid Heart Rate and a feeling of "Flush"\Warm. This lasted about 1-2 minutes.  I did not receive any treatment for this. There was no further outcome to report. After 2 minutes it passed, I remained in the waiting area for an extra 5 minutes following my initial 15 minute observation period and left without incident.
This case was reported by a physician and described the occurrence of dizziness in a female patient who received Shingrix for prophylaxis. On 13th August 2018, the patient received the 2nd dose of Shingrix. On 14th August 2018, 1 days after receiving Shingrix, the patient experienced dizziness, mobility decreased, difficulty in standing, injection site erythema, injection site swelling and skin discoloration. On an unknown date, the outcome of the dizziness, mobility decreased, difficulty in standing and injection site swelling were unknown and the outcome of the injection site erythema and skin discoloration were recovered/resolved. It was unknown if the reporter considered the dizziness, mobility decreased, difficulty in standing, injection site erythema, injection site swelling and skin discoloration to be related to Shingrix. Additional details were provided as follows: The age at the vaccination was not reported. The patient received Shingles Shot in the afternoon. Next day morning, the patient was so dizzy that she could not sit up or stand up with holding onto the sides of the walls. The patient stayed on the couch until it passed around noon. Taking off the bandage the patient could see how pink and swollen it was the top pink spot was where the injection went in (the two dark spots were faded black and blue finger marks where her husband grabbed into her arms as he was unsteady getting up from a chair). The bottom pink was the same color and swollen as the injection site. The patient physically felt okay but the sites were still pink and swollen. The patient asked the pharmacist and she said should definitely let you them know for her records. This case was linked to the case US2018GSK121414, reported by the same reporter.
sick for 2 weeks; Initial information received on 21-Sep-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional via social media.   This case involves a patient (unknown age and gender) who was sick (illness) for 2 weeks, after receiving QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT).  It was unknown if the patient had any medical history, concomitant disease or risk factor.   The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date in 1995, the patient received a dose of suspect FLUZONE HIGH-DOSE QUADRIVALENT (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness, non-serious) for 2 weeks (unknown latency) following the administration of vaccine.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were laboratory data/results available.  It was not reported if the patient received a corrective treatment.   At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
On Sunday 4/18 starting at 4:15pm, my vaccine site began to itch, developed a red rash, and became swollen.  It is still itchy and swollen, however it is not as extreme as it was when symptoms abruptly began.
On 7-5-07 pt developed severe chills, very lethargic, developed unproductive cough and stayed in bed for four days. On 7-11-07 saw PMD, exam, lab work. Pt had UTI and having a drug reaction to new med. Nabumentone, no vaccine related. No urticaria, no joint swelling.
Nausea, headache, muscle ache, exhaustion, chills, low grade fever, and pain at the injection site.
Chills, aches, joint pain, headache, fatigue lasting around 12 hours. Headache and fatigue for 24 hours.
Patient became unconscious after a couple minutes of vaccine administration.  Patient regained consciousness with in two minutes. Her husband mentioned she has a history of loosing consciousness after shots. She was sweating and threw up after she gained consciousness.   911  was called and they checked the patient before the patient departed.  Everything was ok.
Low Grade Fever and Headache; 1 500mg tablet of Acetaminophen (Tylenol) consumed with water on 16th May at 7 PM. Felt better after taking Tylenol. Temperature became normal and headache also reduced.
Redness (erythema) & edema at injection site within 24 hours of Varivax #2 given to R lateral upper arm.
Two days after the vaccine the patient started to get itching at injection site and up and down the arm.  The itching has spread more to the left side of the body.  She also had muscle pain which is quite common. However, she now has pain radiating around her neck and she is kind of stiff.  I advised her to call her doctor if the pain persists and to use hydrocortisone cream on the itching. if the itching gets worse she should also call her doctor
8 pm irritability, crying, didn't sleep, up all night.  10 am mild rash on trunk, decreased appetite.  Normal HEENT, MUG, HRT, Abd exam.
About 12:30 AM on 04/09/2020 patient started shivering and the intensity has increased since then. She started feeling really cold around 12:45 AM and started having pain in both legs and the right side of her torso around that same time. We are currently headed to the ER.
Pt vax w/ 2nd hepta B; exp severe fatigue, aching, nausea.
Patient sitting on exam table and immediately after IM injection he leaned forward and had  vagal response.
Hives onset shortly after admin of Hep A vaccine. Eye swelling, blurry vision, clammy feeling, afebrile, tired, sore throat, feels a bit ill, slept well.
Patient had vasovagal response -- states she usually has this response to vaccines. Given water, juice, crackers. Patient stable, released from vaccination site.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On 20-JAN-2016 the patient was administered with a dose of improperly stored ROTATEQ (lot# L008996 and expiration date 01-DEC-2016, dose, dose# and route not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected since there was no consent for follow up contact.
Approximately half hour after injection patient reports tingling in tongue, heavy chest, SOB, slight difficulty swallowing and flushing in face, at that time HR was 44, O2 sat 99%, and BP 138/80. 50mg of oral  benadryl was given at that time. Patients symptoms continued and 911 was called and at 4:30 epinephrine was instructed to be given IM via epipen. Approximately 5 minutes later EMS arrived, evaluated the patient and no visible signs of allergic reaction were detected. Patients HR and BP were elevated from epinephrine. Myself and another pharmacist remained with patient until approximately 5:30 and at that time the patient was going home. I called her at 6pm that evening and again 11 AM the following morning and no other allergic symptoms were noted.
already got the 2 doses of the vaccine; result came on 26th March positive; This is a spontaneous report from a contactable consumer reported a female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: unknown), via unspecified route of administration in left arm on 11Feb2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received historical vaccine of BNT162B2 in Jan2021 for COVID-19 immunisation (1st dose was 3 weeks before the 2nd dose). It was reported patient was tested on Wednesday 24Mar2021 and the result came on 26Mar2021 positive, already got the 2 doses of the vaccine, the second dose was on 11Feb2021 and the 1st dose was 3 weeks before the 2nd dose. The outcome of the event COVID-19 positive was unknown.  Information about lot/batch number has been requested.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Seizure-Mild
Arm edema, tenderness, erythema at injection site. Fever, chills, body aches, headache.
a slight chill the first night; slight tenderness to arms; This is a spontaneous report from a contactable nurse reported for her identical twin sister. A 64-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications included unspecified flu vaccine on 18Dec2020. The patient experienced a slight chill the first night and slight tenderness to arms on 28Dec2020 with outcome of unknown.    Information about Lot/Batch number requested.
experienced extreme fatigue, vertigo, dizziness, headaches, and migraines and these symptoms have not stopped; experienced extreme fatigue, vertigo, dizziness, headaches, and migraines and these symptoms have not stopped; experienced extreme fatigue, vertigo, dizziness, headaches, and migraines and these symptoms have not stopped; experienced extreme fatigue, vertigo, dizziness, headaches, and migraines and these symptoms have not stopped; experienced extreme fatigue, vertigo, dizziness, headaches, and migraines and these symptoms have not stopped; allergies; This is a spontaneous report from a contactable consumer (patient). A 28-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 02Apr2021 at 18:30 (Batch/Lot Number: ER8730) (at the age of 28-years-old) as second dose, single for COVID-19 immunisation. Medical history neuro-cardiogenic syncope and birth control. Patient has no known allergies. Patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included acacia senegal, ascorbic acid, betacarotene, calcium carbonate, calcium pantothenate, calcium silicate, cellulose microcrystalline, colecalciferol, croscarmellose sodium, cyanocobalamin, dextrin, dl-alpha tocopheryl acetate, ferrous fumarate, folic acid, gelatin, glucose, hypromellose, lecithin, macrogol, magnesium oxide, magnesium stearate, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, silicon dioxide, starch, thiamine mononitrate, titanium dioxide, zinc oxide (ONE-A-DAY WOMEN'S) taken for an unspecified indication, start and stop date were not reported and unspecified medication for birth control. Patient was previously administered with first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EN6207) on 12Mar2021 at 18:30 (at the age of 28-years-old) in the right arm for COVID-19 immunization. Patient reported that shortly after receiving second dose, on 06Apr2021, she experienced extreme fatigue, vertigo, dizziness, headaches, and migraines and these symptoms have not stopped. Patient stated that this may or may not be a result of the vaccine, but the timing is far too coincidental for her to not report this. Patient had seen her doctor multiple times and no conclusive explanation/diagnoses has been given. Due to the headaches, they had tried antihistamines and decongestants to rule out allergies. Patient tried Motrin and Tylenol with no positive results. Patient also tried natural sleeping aids but none of the symptoms have gotten better. Patient even saw an ophthalmologist to ensure it was not vision related. Since the vaccination, the patient has not been tested for COVID-19. The reporter assessed the events as non-serious. Outcome of the events was not recovered.
Patient passed out about 5 minutes after injection. Patient has history of passing out from vaccines, was  counseled to sit and wait 30 minutes after vaccine was given. She passed out in chair in the waiting area about 5 minutes after injection. Nurse practitioner next door was notified and she contacted 911.  Patient then came to but was slightly disoriented, EMS walked patient out to car.
Apprehension, palpitations, anxiety. BP initially 162/94 "settled down to 138/86". Occasionally dropped beat noted but rhythm is mostly regular. Evaluated. Advised to see PMD for BP, and occasional dropped beat. States that she has not been seen by MD for four years. Agreed to follow up with PMD.
5 mins after injection heart rate increased ton170 and blood pressure increased to 180/00 showed no signs of anxiety.  Symptoms subsided within 2 hours
4 YO was administered Boostrix; 4 YO was administered Boostrix; Boostrix administration instead of Infanrix; This case was reported by a nurse via call center representative and described the occurrence of accidental underdose in a 4-year-old patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced accidental underdose, inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the accidental underdose, inappropriate age at vaccine administration and wrong vaccine administered were unknown.   Additional Information: GSK Receipt Date: 22-SEP-2022 Reporter's Comment: The reporter was a nurse. The registered nurse reports a 4 year old patient was administered Boostrix instead of Infanrix. The reporter stated that at the time of call he did not have the patient details, date of administration, lot number, expiration date, or the information of what vaccines were given previously. The Vaccine Administration Facility was the same as Primary Reporter. Additional supportive information: The reporter reported that, they were intending to administer Infanrix and inadvertently administered Boostrix instead of Infanrix, which led to wrong vaccine administered. The patient received Boostrix who was younger than the indicated age which led to inappropriate age at vaccine administration and accidental underdose. This case was 1 of 11 cases for the patient reported by same reporter.; Sender's Comments:  US-GSK-US2022136455:Same reporter US-GSK-US2022136453:Same reporter US-GSK-US2022136454:Same reporter US-GSK-US2022136456:Same reporter US-GSK-US2022136459:Same reporter US-GSK-US2022136461:Same reporter US-GSK-US2022136446:Same reporter US-GSK-US2022136463:Same reporter US-GSK-US2022136451:Same reporter US-GSK-US2022136465:Same reporter
Patient got his vaccine and was sitting in the observation area. About 5 minutes after his dose, I noticed his head roll back. I immediately ran to the patient and asked if he was ok and he quickly "woke up". He said he completely dozed off but patient was unconscious for a moment. We checked his blood pressure which was high initially. Patient refused EMS.
Acute on chronic systolic heart failure. ED visit to hospital admission, This visit was within 6 weeks of receiving the COVID vaccine.
Patient reports "1 week and a day after my second shot I had a full body itchy rash that took a week to go away using Triamcinolone 1%. Then this past saturday (June 19th) I had the same thing starting again. I have an appointment today to see my nurse practitioner. Do you think it could be from the vaccine again?" Denies any other issues after the vaccine. Denies using any new products, medications, walking in any wooded areas etc. No idea how she has this rash.
7/29 2 days after immunizations 10x10 cm erythema (R) thigh at site of KINRIX immunization. Hot and locally tender. No fever, no joint pain. Cool compresses and TYLENOL recommended. Called pt 7/30 AM and resolving/much better. Small 2.5 x 2.5 cm erythema (L) arm at site of Varicella. Hot/tender locally.
26FEB92 c/o soreness lt arm; 28FEB92 c/o lt arm pink & tender 4.5" x 2 1/4 erythemia on lt deltoid, warm to touch & tender on palpation;
pt recv vax 12AUG98 &  exp pain in lt arm & upper portion of shoulder;pt was described as continuous which lasted 2wk & then stopped;pt sought unspecified med attention;
53-year-old female presents the emergency department after being instructed by the oncology nurses to present to the emergency department for further evaluation and management of low platelets.  She notes she got the finds your COVID-19 vaccine 2 weeks ago and then noted bruising of her legs 2 days ago.   Patient exam has petechiae of her lower extremities, abdomen and of the oral mucosa.     Therefore, she was given high-dose dexamethasone and platelets.  She was admitted to the hospital for further evaluation management of her thrombocytopenia, which may be from the COVID-19 vaccine.
pt recv vax 16OCT96 & reported fatigue, emesis & diarrhea that noc;no sx 24hr later;
MMR given 12/16/99, 9 day later, pt developed joint pain and swelling r/ankle, pain and swelling increased over time and spread to l/ankle, knees and bilat. hands and joints. Follow up information on 2/9/00 states these vaccines were not give at our clinic and we didn't have that information-patient does not have that information either-was required to get vaccine for entrance to citrus college.
PATIENT CAME IN STORE ON 2/27/20 COMPLAINING OF SHOULDER PAIN AND RADIATING PAIN DOWN INSIDE OF ARM.  SHE STATES SHE HAD PAIN IN MUSCLE FOR 2 WEEKS IMMEDIATELY AFTER SHOT THEN PAIN BEGAN COMING FROM OTHER PARTS OF HER ARM AND SHOULDER.  THE MUSCLE DOES NOT HURT.  PATIENT HAS NOT SOUGHT TREATMENT OR CARE TO DATE.  SHE WAS ADVISED TO FOLLOW UP WITH HER PCP FOR FURTHER EVALUATION.
pt recvd vax & exp weakness, lightheadedness, dizziness & felt like was going to pass out; later that day pt had completely recovered; No further details were provided;
normal side effects to the first two Moderna Covid-19 vaccinations; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (normal side effects to the first two Moderna Covid-19 vaccinations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (normal side effects to the first two Moderna Covid-19 vaccinations). At the time of the report, VACCINATION COMPLICATION (normal side effects to the first two Moderna Covid-19 vaccinations) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-375294, MOD-2021-375323, MOD-2021-375294.   Reporter did not allow further contact